Evidence for a link between TNFRSF11A and risk of breast cancer

Núria Bonifaci, Marta Palafox, Pasquale Pellegrini, Ana Osorio, Javier Benítez, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Gaia Roversi, Monica Barile, Alessandra Viel, Frederique Mariette, Loris Bernard, Paolo Radice, Bella Kaufman, Yael Laitman, Roni Milgrom, Eitan Friedman, María E. SáezFina Climent, María Teresa Soler, Orland Diez, Judith Balmaña, Adriana Lasa, Teresa Ramón Y Cajal, María Dolores Miramar, Miguel De La Hoya, Pedro Pérez-Segura, Trinidad Caldés, Víctor Moreno, Ander Urruticoechea, Joan Brunet, Conxi Lázaro, Ignacio Blanco, Miguel Angel Pujana, Eva González-Suárez

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Intracellular signaling mediated by the receptor activator of nuclear factor-κB [Rank, encoded by the tumor necrosis factor receptor superfamily, member 11a (Tnfrsf11a) gene] is fundamental for mammary gland development in mice, regulating the expansion of stem and progenitor cell compartments. Conversely, Rank overexpression in mice promotes abnormal proliferation and impairs differentiation, leading to an increased incidence of tumorigenesis. Here, we show that a common genetic variant near the 5′-end of TNFRSF11A, rs7226991, is associated with breast cancer risk in the general population and among carriers of mutations in the breast cancer 2, early onset (BRCA2) gene. Akin to the results of the Cancer and Genetics Markers of Susceptibility initiative, combined analysis of rs7226991 in two Spanish case-control studies (1,365 controls and 1,323 cases in total) revealed a significant association with risk: odds ratio (OR) = 0.88, 95% confidence interval (CI) 0.78-0.98, P trend = 0.025. Subsequent examination of BRCA1 (n = 1,017) and BRCA2 (n = 885) mutation carriers revealed a consistent association in the latter group: weighted hazard ratio (wHR) = 0.70; 95% CI 0.55-0.88; and P trend = 0.003; compared to BRCA1 mutation carriers, wHR = 0.91; 95% CI 0.76-1.10; and P trend = 0.33. The results of this study need to be replicated in other populations and with larger numbers of BRCA1/2 mutation carriers.

Original languageEnglish
Pages (from-to)947-954
Number of pages8
JournalBreast Cancer Research and Treatment
Volume129
Issue number3
DOIs
Publication statusPublished - Oct 2011

Fingerprint

Breast Neoplasms
Mutation
Confidence Intervals
Receptor Activator of Nuclear Factor-kappa B
Stem Cells
Odds Ratio
Human Mammary Glands
Genetic Predisposition to Disease
Cytoplasmic and Nuclear Receptors
Genetic Markers
Population
Genes
Case-Control Studies
Carcinogenesis
Incidence
Neoplasms

Keywords

  • BRCA1/2 mutation carriers
  • Breast cancer
  • RANK
  • TNFRSF11A

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Bonifaci, N., Palafox, M., Pellegrini, P., Osorio, A., Benítez, J., Peterlongo, P., ... González-Suárez, E. (2011). Evidence for a link between TNFRSF11A and risk of breast cancer. Breast Cancer Research and Treatment, 129(3), 947-954. https://doi.org/10.1007/s10549-011-1546-7

Evidence for a link between TNFRSF11A and risk of breast cancer. / Bonifaci, Núria; Palafox, Marta; Pellegrini, Pasquale; Osorio, Ana; Benítez, Javier; Peterlongo, Paolo; Manoukian, Siranoush; Peissel, Bernard; Zaffaroni, Daniela; Roversi, Gaia; Barile, Monica; Viel, Alessandra; Mariette, Frederique; Bernard, Loris; Radice, Paolo; Kaufman, Bella; Laitman, Yael; Milgrom, Roni; Friedman, Eitan; Sáez, María E.; Climent, Fina; Soler, María Teresa; Diez, Orland; Balmaña, Judith; Lasa, Adriana; Ramón Y Cajal, Teresa; Miramar, María Dolores; De La Hoya, Miguel; Pérez-Segura, Pedro; Caldés, Trinidad; Moreno, Víctor; Urruticoechea, Ander; Brunet, Joan; Lázaro, Conxi; Blanco, Ignacio; Pujana, Miguel Angel; González-Suárez, Eva.

In: Breast Cancer Research and Treatment, Vol. 129, No. 3, 10.2011, p. 947-954.

Research output: Contribution to journalArticle

Bonifaci, N, Palafox, M, Pellegrini, P, Osorio, A, Benítez, J, Peterlongo, P, Manoukian, S, Peissel, B, Zaffaroni, D, Roversi, G, Barile, M, Viel, A, Mariette, F, Bernard, L, Radice, P, Kaufman, B, Laitman, Y, Milgrom, R, Friedman, E, Sáez, ME, Climent, F, Soler, MT, Diez, O, Balmaña, J, Lasa, A, Ramón Y Cajal, T, Miramar, MD, De La Hoya, M, Pérez-Segura, P, Caldés, T, Moreno, V, Urruticoechea, A, Brunet, J, Lázaro, C, Blanco, I, Pujana, MA & González-Suárez, E 2011, 'Evidence for a link between TNFRSF11A and risk of breast cancer', Breast Cancer Research and Treatment, vol. 129, no. 3, pp. 947-954. https://doi.org/10.1007/s10549-011-1546-7
Bonifaci N, Palafox M, Pellegrini P, Osorio A, Benítez J, Peterlongo P et al. Evidence for a link between TNFRSF11A and risk of breast cancer. Breast Cancer Research and Treatment. 2011 Oct;129(3):947-954. https://doi.org/10.1007/s10549-011-1546-7
Bonifaci, Núria ; Palafox, Marta ; Pellegrini, Pasquale ; Osorio, Ana ; Benítez, Javier ; Peterlongo, Paolo ; Manoukian, Siranoush ; Peissel, Bernard ; Zaffaroni, Daniela ; Roversi, Gaia ; Barile, Monica ; Viel, Alessandra ; Mariette, Frederique ; Bernard, Loris ; Radice, Paolo ; Kaufman, Bella ; Laitman, Yael ; Milgrom, Roni ; Friedman, Eitan ; Sáez, María E. ; Climent, Fina ; Soler, María Teresa ; Diez, Orland ; Balmaña, Judith ; Lasa, Adriana ; Ramón Y Cajal, Teresa ; Miramar, María Dolores ; De La Hoya, Miguel ; Pérez-Segura, Pedro ; Caldés, Trinidad ; Moreno, Víctor ; Urruticoechea, Ander ; Brunet, Joan ; Lázaro, Conxi ; Blanco, Ignacio ; Pujana, Miguel Angel ; González-Suárez, Eva. / Evidence for a link between TNFRSF11A and risk of breast cancer. In: Breast Cancer Research and Treatment. 2011 ; Vol. 129, No. 3. pp. 947-954.
@article{b19236373a804a279251c9aecd12c1ba,
title = "Evidence for a link between TNFRSF11A and risk of breast cancer",
abstract = "Intracellular signaling mediated by the receptor activator of nuclear factor-κB [Rank, encoded by the tumor necrosis factor receptor superfamily, member 11a (Tnfrsf11a) gene] is fundamental for mammary gland development in mice, regulating the expansion of stem and progenitor cell compartments. Conversely, Rank overexpression in mice promotes abnormal proliferation and impairs differentiation, leading to an increased incidence of tumorigenesis. Here, we show that a common genetic variant near the 5′-end of TNFRSF11A, rs7226991, is associated with breast cancer risk in the general population and among carriers of mutations in the breast cancer 2, early onset (BRCA2) gene. Akin to the results of the Cancer and Genetics Markers of Susceptibility initiative, combined analysis of rs7226991 in two Spanish case-control studies (1,365 controls and 1,323 cases in total) revealed a significant association with risk: odds ratio (OR) = 0.88, 95{\%} confidence interval (CI) 0.78-0.98, P trend = 0.025. Subsequent examination of BRCA1 (n = 1,017) and BRCA2 (n = 885) mutation carriers revealed a consistent association in the latter group: weighted hazard ratio (wHR) = 0.70; 95{\%} CI 0.55-0.88; and P trend = 0.003; compared to BRCA1 mutation carriers, wHR = 0.91; 95{\%} CI 0.76-1.10; and P trend = 0.33. The results of this study need to be replicated in other populations and with larger numbers of BRCA1/2 mutation carriers.",
keywords = "BRCA1/2 mutation carriers, Breast cancer, RANK, TNFRSF11A",
author = "N{\'u}ria Bonifaci and Marta Palafox and Pasquale Pellegrini and Ana Osorio and Javier Ben{\'i}tez and Paolo Peterlongo and Siranoush Manoukian and Bernard Peissel and Daniela Zaffaroni and Gaia Roversi and Monica Barile and Alessandra Viel and Frederique Mariette and Loris Bernard and Paolo Radice and Bella Kaufman and Yael Laitman and Roni Milgrom and Eitan Friedman and S{\'a}ez, {Mar{\'i}a E.} and Fina Climent and Soler, {Mar{\'i}a Teresa} and Orland Diez and Judith Balma{\~n}a and Adriana Lasa and {Ram{\'o}n Y Cajal}, Teresa and Miramar, {Mar{\'i}a Dolores} and {De La Hoya}, Miguel and Pedro P{\'e}rez-Segura and Trinidad Cald{\'e}s and V{\'i}ctor Moreno and Ander Urruticoechea and Joan Brunet and Conxi L{\'a}zaro and Ignacio Blanco and Pujana, {Miguel Angel} and Eva Gonz{\'a}lez-Su{\'a}rez",
year = "2011",
month = "10",
doi = "10.1007/s10549-011-1546-7",
language = "English",
volume = "129",
pages = "947--954",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York LLC",
number = "3",

}

TY - JOUR

T1 - Evidence for a link between TNFRSF11A and risk of breast cancer

AU - Bonifaci, Núria

AU - Palafox, Marta

AU - Pellegrini, Pasquale

AU - Osorio, Ana

AU - Benítez, Javier

AU - Peterlongo, Paolo

AU - Manoukian, Siranoush

AU - Peissel, Bernard

AU - Zaffaroni, Daniela

AU - Roversi, Gaia

AU - Barile, Monica

AU - Viel, Alessandra

AU - Mariette, Frederique

AU - Bernard, Loris

AU - Radice, Paolo

AU - Kaufman, Bella

AU - Laitman, Yael

AU - Milgrom, Roni

AU - Friedman, Eitan

AU - Sáez, María E.

AU - Climent, Fina

AU - Soler, María Teresa

AU - Diez, Orland

AU - Balmaña, Judith

AU - Lasa, Adriana

AU - Ramón Y Cajal, Teresa

AU - Miramar, María Dolores

AU - De La Hoya, Miguel

AU - Pérez-Segura, Pedro

AU - Caldés, Trinidad

AU - Moreno, Víctor

AU - Urruticoechea, Ander

AU - Brunet, Joan

AU - Lázaro, Conxi

AU - Blanco, Ignacio

AU - Pujana, Miguel Angel

AU - González-Suárez, Eva

PY - 2011/10

Y1 - 2011/10

N2 - Intracellular signaling mediated by the receptor activator of nuclear factor-κB [Rank, encoded by the tumor necrosis factor receptor superfamily, member 11a (Tnfrsf11a) gene] is fundamental for mammary gland development in mice, regulating the expansion of stem and progenitor cell compartments. Conversely, Rank overexpression in mice promotes abnormal proliferation and impairs differentiation, leading to an increased incidence of tumorigenesis. Here, we show that a common genetic variant near the 5′-end of TNFRSF11A, rs7226991, is associated with breast cancer risk in the general population and among carriers of mutations in the breast cancer 2, early onset (BRCA2) gene. Akin to the results of the Cancer and Genetics Markers of Susceptibility initiative, combined analysis of rs7226991 in two Spanish case-control studies (1,365 controls and 1,323 cases in total) revealed a significant association with risk: odds ratio (OR) = 0.88, 95% confidence interval (CI) 0.78-0.98, P trend = 0.025. Subsequent examination of BRCA1 (n = 1,017) and BRCA2 (n = 885) mutation carriers revealed a consistent association in the latter group: weighted hazard ratio (wHR) = 0.70; 95% CI 0.55-0.88; and P trend = 0.003; compared to BRCA1 mutation carriers, wHR = 0.91; 95% CI 0.76-1.10; and P trend = 0.33. The results of this study need to be replicated in other populations and with larger numbers of BRCA1/2 mutation carriers.

AB - Intracellular signaling mediated by the receptor activator of nuclear factor-κB [Rank, encoded by the tumor necrosis factor receptor superfamily, member 11a (Tnfrsf11a) gene] is fundamental for mammary gland development in mice, regulating the expansion of stem and progenitor cell compartments. Conversely, Rank overexpression in mice promotes abnormal proliferation and impairs differentiation, leading to an increased incidence of tumorigenesis. Here, we show that a common genetic variant near the 5′-end of TNFRSF11A, rs7226991, is associated with breast cancer risk in the general population and among carriers of mutations in the breast cancer 2, early onset (BRCA2) gene. Akin to the results of the Cancer and Genetics Markers of Susceptibility initiative, combined analysis of rs7226991 in two Spanish case-control studies (1,365 controls and 1,323 cases in total) revealed a significant association with risk: odds ratio (OR) = 0.88, 95% confidence interval (CI) 0.78-0.98, P trend = 0.025. Subsequent examination of BRCA1 (n = 1,017) and BRCA2 (n = 885) mutation carriers revealed a consistent association in the latter group: weighted hazard ratio (wHR) = 0.70; 95% CI 0.55-0.88; and P trend = 0.003; compared to BRCA1 mutation carriers, wHR = 0.91; 95% CI 0.76-1.10; and P trend = 0.33. The results of this study need to be replicated in other populations and with larger numbers of BRCA1/2 mutation carriers.

KW - BRCA1/2 mutation carriers

KW - Breast cancer

KW - RANK

KW - TNFRSF11A

UR - http://www.scopus.com/inward/record.url?scp=80052577712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052577712&partnerID=8YFLogxK

U2 - 10.1007/s10549-011-1546-7

DO - 10.1007/s10549-011-1546-7

M3 - Article

C2 - 21541702

AN - SCOPUS:80052577712

VL - 129

SP - 947

EP - 954

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -